This supports previous in vitro data suggesting that Nrf2 may be associated with the enhanced expression of HO-1 in bladder cancer cells [10], which in turn enhances pathological angiogenesis in tumors and the viability of cells during therapy [10,24,25,26]. The gene discussed is HMOX1; the disease is urinary bladder cancer.